About Censa Pharmaceuticals
Censa Pharmaceuticals is a company based in Cambridge (United States) founded in 2015 was acquired by PTC Therapeutics in May 2020.. Censa Pharmaceuticals has raised $3.01 million across 2 funding rounds from investors including PTC Therapeutics. The company has 2 employees as of December 31, 2022. Censa Pharmaceuticals operates in a competitive market with competitors including Harmony Biosciences, QurAlis, Evox Therapeutics, Passage Bio and Longboard Pharmaceutical, among others.
- Headquarter Cambridge, United States
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Censa Pharmaceuticals Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.01 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
Nov 21, 2017
- Investors
-
Employee Count
2
as on Dec 31, 2022
-
Acquired by
PTC Therapeutics
(May 06, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Censa Pharmaceuticals
Censa Pharmaceuticals has successfully raised a total of $3.01M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.5M
-
First Round
First Round
(19 Apr 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Seed - Censa Pharmaceuticals | Valuation |
investors |
|
| Apr, 2016 | Amount | Seed - Censa Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Censa Pharmaceuticals
Censa Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PTC Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule drugs for rare diseases are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Censa Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Censa Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Censa Pharmaceuticals Comparisons
Competitors of Censa Pharmaceuticals
Censa Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Harmony Biosciences, QurAlis, Evox Therapeutics, Passage Bio and Longboard Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutics for rare neurological diseases
|
|
| domain | founded_year | HQ Location |
Drugs and CSF devices are developed for ALS treatment.
|
|
| domain | founded_year | HQ Location |
Exosome-based gene therapies for neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for CNS rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for rare neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
CNS therapeutics are developed via regenerative medicine for disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Censa Pharmaceuticals
Frequently Asked Questions about Censa Pharmaceuticals
When was Censa Pharmaceuticals founded?
Censa Pharmaceuticals was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Censa Pharmaceuticals located?
Censa Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Censa Pharmaceuticals a funded company?
Censa Pharmaceuticals is a funded company, having raised a total of $3.01M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.51M, raised on Apr 19, 2016.
How many employees does Censa Pharmaceuticals have?
As of Dec 31, 2022, the latest employee count at Censa Pharmaceuticals is 2.
What does Censa Pharmaceuticals do?
Founded in 2015 in Cambridge, United States, Censa Pharmaceuticals operates in the pharmaceutical sector at the preclinical stage. Drugs are developed for rare central nervous system disorders, emphasizing issues in neurotransmitter degradation and synthesis. The lead candidate, CNSA-001, advances through discovery for Tetrahydrobiopterin deficiency, which involves shortages of BH4 and altered phenylalanine levels. FDA and EMA approvals are targeted within four years, while parallel programs address broader CNS conditions.
Who are the top competitors of Censa Pharmaceuticals?
Censa Pharmaceuticals's top competitors include Harmony Biosciences, QurAlis and MindMed.
Who are Censa Pharmaceuticals's investors?
Censa Pharmaceuticals has 1 investor. Key investors include PTC Therapeutics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.